Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus
Clinical trial NCT02441543 · COMPLETED
Trial details
- NCT number
- NCT02441543
- Sponsor
- Istituto Clinico Humanitas
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-04-01
- Primary completion
- 2018-04-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.